Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing 100088, P.R. China.
Shanghai Institute of Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, P.R. China.
Int J Mol Med. 2019 Jun;43(6):2429-2439. doi: 10.3892/ijmm.2019.4159. Epub 2019 Apr 9.
Cerebral ischemia‑reperfusion injury (CIRI) usually causes detrimental complications following reperfusion therapy in stroke patients. The present study systematically investigated the regulatory mechanism involved in the pathogenesis of CIRI using gene set enrichment analysis of the transient middle cerebral artery occlusion mouse stroke model. The results revealed a total of 13 CIRI‑related transcription factors (TFs), including CCAAT enhancer binding protein b (Cebpb), Cebpa, early growth response‑1, Fos, Rela, Jund, signal transduction and activator of transcription 5a/b, transformation related protein 53, GLI family zinc finger 2 (Gli2), Sp3, TF AP‑2 α (Tfap2a) and spleen focus forming virus proviral integration oncogene (Spi1). To the best of our knowledge, five TFs (Cebpa, Gli2, Sp3, Tfap2a and Spi1) were the first to be reported associated with CIRI in the present study. The five novel CIRI‑related TFs were mainly associated with pathways of inflammation and responses to reperfusion, including the tumor necrosis factor signaling pathway (Gli2, Spi1 and Tfap2a, P=0.0035, 0.0035 and 0.048, respectively), interleuking‑17 signaling pathway (Cebpa, Gli2, Sp3, Spi1 and Tfap2a, P=0.019, 0.047, 0.019, 0.035 and 0.005, respectively) and fluid shear stress and atherosclerosis (Gli2, Sp3, Spi1 and Tfap2a, P=0.047, 0.046, 0.013 and 0.003, respectively). These results may improve understanding of the potential molecular mechanism underlying the pathogenesis of CIRI at the genome‑wide level.
脑缺血再灌注损伤(CIRI)通常会在中风患者的再灌注治疗后引起有害的并发症。本研究采用短暂性大脑中动脉闭塞小鼠中风模型的基因集富集分析,系统地研究了 CIRI 发病机制中的调节机制。结果共发现 13 个与 CIRI 相关的转录因子(TFs),包括 CCAAT 增强子结合蛋白 b(Cebpb)、Cebpa、早期生长反应-1、Fos、Rela、Jund、信号转导和转录激活因子 5a/b、转化相关蛋白 53、GLI 家族锌指 2(Gli2)、Sp3、TF AP-2α(Tfap2a)和脾焦点形成病毒前病毒整合致癌基因(Spi1)。据我们所知,在本研究中,有五个 TF(Cebpa、Gli2、Sp3、Tfap2a 和 Spi1)是首次报道与 CIRI 相关的。这五个新的与 CIRI 相关的 TF 主要与炎症和再灌注反应途径相关,包括肿瘤坏死因子信号通路(Gli2、Spi1 和 Tfap2a,P=0.0035、0.0035 和 0.048)、白细胞介素-17 信号通路(Cebpa、Gli2、Sp3、Spi1 和 Tfap2a,P=0.019、0.047、0.019、0.035 和 0.005)和流体切应力和动脉粥样硬化(Gli2、Sp3、Spi1 和 Tfap2a,P=0.047、0.046、0.013 和 0.003)。这些结果可能会提高对全基因组水平上 CIRI 发病机制潜在分子机制的理解。